PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates. Sammour Y, Dezorzi C, Austin BA, Borkon AM, et al. J Card Fail 2021;27:812-815.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sammour Y, Dezorzi C, Austin BA, Borkon AM, et al. PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates. J Card Fail 2021;27:812-815.
PMID: 33753241